RBC Capital Reiterates Sector Perform on Regenxbio, Maintains $20 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Luca Issi has reiterated a 'Sector Perform' rating on Regenxbio (NASDAQ:RGNX) and maintained a $20 price target.
October 04, 2023 | 1:49 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Regenxbio's stock rating has been reiterated as 'Sector Perform' by RBC Capital, with a maintained price target of $20.
The reiteration of the 'Sector Perform' rating and the maintenance of the $20 price target by RBC Capital indicates that the analyst sees no significant changes in the company's performance. This is likely to have a neutral impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100